Differentially expressed genes associated with <i><scp>CIS</scp></i>‐diamminedichloroplatinum (II) resistance in head and neck cancer using differential display and <i><scp>C</scp></i>DNA microarray

Abstract

Our findings suggest that development of the cDDP-resistant phenotype is accompanied by alternations of gene expression including a glycoprotein hormone and membrane proteins. These gene products could be new molecular markers for resistance to cDDP.